These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23675978)
1. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549. Yadav DK; Kalani K; Khan F; Srivastava SK Med Chem; 2013 Dec; 9(8):1073-84. PubMed ID: 23675978 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro evaluation of 18β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7. Yadav DK; Kalani K; Singh AK; Khan F; Srivastava SK; Pant AB Curr Med Chem; 2014; 21(9):1160-70. PubMed ID: 24180274 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents. Parida PK; Sau A; Ghosh T; Jana K; Biswas K; Raha S; Misra AK Bioorg Med Chem Lett; 2014 Aug; 24(16):3865-8. PubMed ID: 25027936 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives. Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity. Gao C; Dai FJ; Cui HW; Peng SH; He Y; Wang X; Yi ZF; Qiu WW Chem Biol Drug Des; 2014 Aug; 84(2):223-33. PubMed ID: 24612785 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives. Li Y; Feng L; Song ZF; Li HB; Huai QY Molecules; 2016 Feb; 21(2):. PubMed ID: 26861280 [TBL] [Abstract][Full Text] [Related]
8. Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance. Jin L; Huang R; Huang X; Zhang B; Ji M; Wang H Bioorg Med Chem; 2018 May; 26(8):1759-1775. PubMed ID: 29486954 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid. Csuk R; Schwarz S; Kluge R; Ströhl D Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents. Zhou F; Wu GR; Cai DS; Xu B; Yan MM; Ma T; Guo WB; Zhang WX; Huang XM; Jia XH; Yang YQ; Gao F; Wang PL; Lei HM Eur J Med Chem; 2019 Sep; 178():623-635. PubMed ID: 31226654 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and Antiproliferative Activity of Novel A-Ring Cleaved Glycyrrhetinic Acid Derivatives. Alho DPS; Salvador JAR; Cascante M; Marin S Molecules; 2019 Aug; 24(16):. PubMed ID: 31416117 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives. Alho DPS; Salvador JAR; Cascante M; Marin S Molecules; 2019 Feb; 24(4):. PubMed ID: 30791593 [TBL] [Abstract][Full Text] [Related]
13. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability. Li K; Ma T; Cai J; Huang M; Guo H; Zhou D; Luan S; Yang J; Liu D; Jing Y; Zhao L Bioorg Med Chem; 2017 Oct; 25(20):5441-5451. PubMed ID: 28838831 [TBL] [Abstract][Full Text] [Related]
14. An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents. Xu B; Wu GR; Zhang XY; Yan MM; Zhao R; Xue NN; Fang K; Wang H; Chen M; Guo WB; Wang PL; Lei HM Molecules; 2017 Jun; 22(6):. PubMed ID: 28574470 [TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of New Anticancer Glycyrrhetinic Acids and Oleanolic Acids. Wang R; Zheng QX; Wang W; Feng L; Li HJ; Huai QY Biol Pharm Bull; 2017; 40(5):703-710. PubMed ID: 28458357 [TBL] [Abstract][Full Text] [Related]
16. QSAR guided semi-synthesis and in-vitro validation of anticancer activity in ursolic acid derivatives. Kalani K; Yadav DK; Singh A; Khan F; Godbole MM; Srivastava SK Curr Top Med Chem; 2014; 14(8):1005-13. PubMed ID: 24660684 [TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Silico Studies of Glycyrrhetinic Acid Derivatives as Anti- Filarial Agents. Tyagi R; Verma S; Mishra S; Srivastava M; Alam S; Khan F; Srivastava SK Curr Top Med Chem; 2019; 19(14):1191-1200. PubMed ID: 31210109 [TBL] [Abstract][Full Text] [Related]
18. A "natural" approach: synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosides. Schwarz S; Siewert B; Xavier NM; Jesus AR; Rauter AP; Csuk R Eur J Med Chem; 2014 Jan; 72():78-83. PubMed ID: 24361520 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties. Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427 [TBL] [Abstract][Full Text] [Related]
20. Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation. Jin L; Zhang B; Hua S; Ji M; Huang X; Huang R; Wang H Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3700-3707. PubMed ID: 30528976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]